Literature DB >> 26868330

Prognostic Significance of Preoperative Serum Lactate Dehydrogenase in Upper Urinary Tract Urothelial Carcinoma.

Xin-Ke Zhang1, Zhi-Ling Zhang2, Xu Lu3, Ping Yang1, Mu-Yan Cai1, Wan-Ming Hu1, Jing-Ping Yun1, Fang-Jian Zhou2, Chao-Nan Qian4, Yun Cao5.   

Abstract

BACKGROUND: Upper urinary tract urothelial carcinoma (UUTUC) is one of the uncommon malignancies lacking of prognostic indicators. Lactate dehydrogenase (LDH) has been demonstrated to correlate with clinical outcomes in human cancers. In this study, we aimed to evaluate the prognostic implication of the preoperative LDH in UUTUC. PATIENTS AND METHODS: A cohort of 100 UUTUC samples along with the preoperative LDH value was recruited from January 1990 to June 2011. The cutoff value was set at 245 u/L for the upper value of normal limitation. Univariate and multivariate analyses were conducted to determine the association of LDH with overall survival (OS) and disease-free survival (DFS).
RESULTS: Kaplan-Meier analysis revealed that high level of LDH (> 245 u/L) was significantly associated with poor OS (P < .001) and DFS (P = .002). Multivariate Cox proportional analysis indicated LDH, controlled by vascular invasion, pathological stage, lymph node status, subsequent bladder tumor, tumor grade, tumor necrosis, architecture, and multifocality, was as an independent predictor of OS (hazard ratio, 3.181; 95% confidence interval, 1.223-8.276; P = .018) and DFS (hazard ratio, 3.041; 95% confidence interval, 1.247-7.417; P = .015). Stratified showed that elevated serum LDH was correlated with the worse OS in patients without lymph node metastasis (P = .002) and those at advanced pathological stage (P < .001).
CONCLUSION: The preoperative LDH was an independent prognostic factor for patients with UUTUC and could be used as a risk factor to predict the tumor aggressiveness.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Disease-free survival; Lactate dehydrogenase; Overall survival; Prognosis; Upper urinary tract urothelial carcinoma

Mesh:

Substances:

Year:  2016        PMID: 26868330     DOI: 10.1016/j.clgc.2016.01.003

Source DB:  PubMed          Journal:  Clin Genitourin Cancer        ISSN: 1558-7673            Impact factor:   2.872


  4 in total

1.  Significance of multiple preoperative laboratory abnormalities as prognostic indicators in patients with urothelial carcinoma of the upper urinary tract following radical nephroureterectomy.

Authors:  Masatomo Nishikawa; Hideaki Miyake; Toshifumi Kurahashi; Masato Fujisawa
Journal:  Int J Clin Oncol       Date:  2017-08-30       Impact factor: 3.402

2.  Prognostic value of pretreatment serum lactate dehydrogenase level in pancreatic cancer patients: A meta-analysis of 18 observational studies.

Authors:  Jianxin Gan; Wenhu Wang; Zengxi Yang; Jiebin Pan; Liang Zheng; Lanning Yin
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.817

3.  Is preoperative serum lactate dehydrogenase useful in predicting the outcomes of patients with upper tract urothelial carcinoma?

Authors:  Ping Tan; Jie Chen; Nan Xie; Hang Xu; Jianzhong Ai; Huan Xu; Liangren Liu; Lu Yang; Qiang Wei
Journal:  Cancer Med       Date:  2018-08-27       Impact factor: 4.452

4.  Three hematological indexes that may serve as prognostic indicators in patients with primary, high-grade, appendicular osteosarcoma.

Authors:  Keqi Hu; Zhan Wang; Peng Lin; Zuojun Wen; Haiyong Ren; Lingling Sun; Hengyuan Li; Binghao Li; Shengdong Wang; Xingzhi Zhou; Siyuan Tengwang; Langhai Xu; Zhaoming Ye
Journal:  Oncotarget       Date:  2017-06-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.